NCT07562100 Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer
| NCT ID | NCT07562100 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Veterans General Hospital, Taiwan |
| Condition | Oral Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 650 participants |
| Start Date | 2024-09-27 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 650 participants in total. It began in 2024-09-27 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to develop and evaluate an Artificial Intelligence Assisted Prehabilitation Program (AI APP) for returning to work and cost-effectiveness analysis in patients with oral cancer (OC). The main questions it aims to answer are: * What kinds of needs are related to returning to work (RTW) in patients with OC from diagnosis to survival that we can incorporate into the development of AI APP to assist this population ? * How is the effect of the AI APP that based on findings from the first question for patients with OC on physical and psychological distress, fear of recurrence, self-efficacy in coping with cancer, communication, motor function, quality of life, and RTW? * How is the effect of the RTW AI prediction model to identify high-risk groups ? And how is the comprehensive cost effectiveness of benefits and quality of life of the AI APP for OC population? Researchers will compare patients without using AI APP to see if the AI APP works to assist with coping physical and psychological distress, communication, motor function, quality of life, and RTW issues for individuals with OC? Participants will: * Be asked to fulfill a structural questionnaire, or engage in a semi-structured one-by-one interview or a focus group to assess their physical, psychological, and social support needs in the first stage. * Be invited to participant the pilot testing of AI APP in the second stage. * Be provided and trained by 3-month AI APP for 3 months or cared as usual in the third stage. * Complete a structural questionnaire and follow up one year, including the baseline (before using the AI app) and at 1-2 weeks, 3 months, 6 months, 9 months, and 12 months after the baseline. * Engage in one-by-one interview or a focus group to assess user experiences of the AI APP.
Eligibility Criteria
Inclusion Criteria: * Adult (\> 20 years old and younger than 70 years old) * Newly diagnosed as OC and scheduled to receive cancer-related treatment * Able to use Mobile phone * Willing to sign an informed consent form after receiving a detailed explanation of the study's aims and procedures * Healthcare professionals involved in patients' care, including doctors, nurses, case managers, dietitians, rehabilitation therapists, and psychologists * Family members who are primary caregivers of the participating patients, engaged in different stages of medical care Exclusion Criteria: * Risk populations for walking or performing exercise * Patients with cognitive impairment or psychiatric diseases
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07562100 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Oral Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07562100 currently recruiting?
Yes, NCT07562100 is actively recruiting participants. Contact the research team at scshun@nycu.edu.tw for enrollment information.
Where is the NCT07562100 trial being conducted?
This trial is being conducted at Taipei, Taiwan, Taipei, Taiwan, Taipei, Taiwan, Taipei, Taiwan and 1 additional location.
Who is sponsoring the NCT07562100 clinical trial?
NCT07562100 is sponsored by Taipei Veterans General Hospital, Taiwan. The trial plans to enroll 650 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.